Dexcom Inc
DXCM · Healthcare · Health Care
Updated 24 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #308 of 500 by Iconic Score · #41 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Dexcom Inc. (DXCM) is a leading company in the healthcare sector, specializing in continuous glucose monitoring (CGM) systems for individuals with diabetes. With a market capitalization of $28.7 billion, Dexcom has established a strong position in the diabetes management market, offering innovative technology that enables real-time glucose monitoring and data sharing. Its flagship products, which include wearable sensors and mobile applications, empower patients to manage their condition more effectively and improve health outcomes. The company's commitment to research and development, along with strategic partnerships, positions it well to capitalize on the growing demand for diabetes management solutions as global diabetes prevalence increases. Dexcom's advancements not only enhance patient quality of life but also contribute to the broader healthcare landscape by promoting proactive disease management and reducing long-term healthcare costs.
IconicOracleAI™ Brief
Dexcom Inc's Iconic Score of 39 reflects a challenging brand perception amid increasing competition in the glucose monitoring market, particularly from Abbott's Libre. Despite strong results from the G7 in Type 2 diabetes studies, the company's stock price has recently declined by 4.76%. However, a high brand-visibility signal of 85 indicates significant recognition, suggesting that while market dynamics are tough, Dexcom remains a notable player in the wearable electronics and digital health sectors.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.